COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients

Objectives: Patients with haematologic malignancies (HM) COVID-19 have more severe disease, with increased risk of mortality. Therefore, this study aimed to evaluate the effect of SARS-CoV-2 RNAemia and the specific humoral immune responses on the clinical outcomes of patients with HM and COVID-19....

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Javier Martín-Escolano, Sonsoles Salto-Alejandre, Carmen Infante-Domínguez, Marta Carretero-Ledesma, Natalia Maldonado-Lizarazo, Pedro Camacho-Martínez, Francisco Martín-Domínguez, Inmaculada Tallón-Ruiz, Ana Ruiz-Molina, Zaira Palacios-Baena, Patricia Pérez-Palacios, María Paniagua-García, Rocío Álvarez-Marín, Laura Merino, José Miguel Cisneros, Elisa Cordero, Jerónimo Pachón, José Antonio Pérez-Simón, Javier Sánchez-Céspedes, Manuela Aguilar-Guisado
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2024-09-01
Cyfres:	International Journal of Infectious Diseases
Pynciau:	COVID-19 SARS-CoV-2 RNAemia Haematologic malignancies Clinical outcome
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1201971224002340
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!